Radiation Oncology Journal

Citations to this article as recorded by

Diffuse Pneumonitis after Lutetium-177-PSMA-617 Treatment in a Patient with Metastatic Castration-Resistant Prostate Cancer

John S Wang, Terence Wong, Kevin A Wu, Trey C Mullikin, Andrew Armstrong

BMJ Case Reports.2024; 17(2): e257772. CrossRef

Volumetric modulated arc therapy (VMAT) comparison to 3D‐conformal technique in lung stereotactic ablative radiotherapy (SABR)

Frances Mark, Anoud Alnsour, Scott N. Penfold, Adrian Esterman, Robert Keys, Hien Le

Journal of Medical Radiation Sciences.2023; 70(1): 72. CrossRef

Continuing professional development – Radiation therapy

Journal of Medical Radiation Sciences.2023; 70(1): 100. CrossRef

Importance of Local Ablative Therapies for Lung Metastases in Patients With Colorectal Cancer

Byung Min Lee, Jee Suk Chang, Woong Sub Koom, Hwa Kyung Byun, Han Sang Kim, Seung-Hoon Beom, Caleb Oh, Young Joo Suh, Joong Bae Ahn, Sang Joon Shin, Byung Jo Park, Seong Yong Park

Annals of Surgery.2023; 278(1): e173. CrossRef

Developing a Prediction Model for Radiation Pneumonitis in Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy Combined With Clinical, Dosimetric Factors, and Laboratory Biomarkers

Bao-Tian Huang, Pei-Xian Lin, Ying Wang, Li-Mei Luo

Clinical Lung Cancer.2023; 24(8): e323. CrossRef

Artificial Intelligence in Lung Cancer: Bridging the Gap Between Computational Power and Clinical Decision-Making

Jaryd R. Christie, Pencilla Lang, Lauren M. Zelko, David A. Palma, Mohamed Abdelrazek, Sarah A. Mattonen

Canadian Association of Radiologists Journal.2021; 72(1): 86. CrossRef

Clinical and dosimetric predictors of radiation pneumonitis in early-stage lung cancer treated with Stereotactic Ablative radiotherapy (SABR) – An analysis of UK’s largest cohort of lung SABR patients

Animesh Saha, Matthew Beasley, Nathaniel Hatton, Peter Dickinson, Kevin Franks, Katy Clarke, Pooja Jain, Mark Teo, Patrick Murray, John Lilley

Radiotherapy and Oncology.2021; 156: 153. CrossRef

Comparison of Radiation Pneumonitis in Lung Cancer Patients Treated with HT versus IMRT and Circulating Lymphocyte Subsets as Predicting Risk Factors

Xin Zhang, Dingyi Yang, Yong Jiang, Luo Huang, Can Wang, Dan Tao, Xianfeng Liu, Yongyang Lei, Yongzhong Wu, Wei Zhou

Journal of Inflammation Research.2021; Volume 14: 4205. CrossRef

Computed tomography-based radiomic model predicts radiological response following stereotactic body radiation therapy in early-stage non-small-cell lung cancer and pulmonary oligo-metastases

Ben Man Fei Cheung, Kin Sang Lau, Victor Ho Fun Lee, To Wai Leung, Feng-Ming Spring Kong, Mai Yee Luk, Kwok Keung Yuen

Radiation Oncology Journal.2021; 39(4): 254. CrossRef

The Efficacy and Safety of Acupuncture for Preventing Radiation Pneumonitis in Patients With Lung Cancer: A Prospective, Single-Blinded, Randomized Pilot Proof-of-Principle Study

Moonkyoo Kong, Seung Hyeun Lee, Jaehyo Kim, Beom-Joon Lee, Kwan-Il Kim

Integrative Cancer Therapies.2020; 19: 153473542090832. CrossRef

Distinguishing Radiation Pneumonitis from Local Tumour Recurrence Following SBRT for Lung Cancer

Reports in Medical Imaging.2020; Volume 13: 1. CrossRef

Radiation-induced lung injury: latest molecular developments, therapeutic approaches, and clinical guidance

Lina Lu, Chao Sun, Qiong Su, Yanbin Wang, Jia Li, Zhong Guo, Lihua Chen, Hong Zhang

Clinical and Experimental Medicine.2019; 19(4): 417. CrossRef

HSP27 inhibitor attenuates radiation-induced pulmonary inflammation

Jee-Youn Kim, Yong-Min An, Byeong Rok Yoo, Jin-Mo Kim, Song Yee Han, Younghwa Na, Yun-Sil Lee, Jaeho Cho

Scientific Reports.2018;[Epub] CrossRef

Evolution of Stereotactic Ablative Radiotherapy in Lung Cancer and Birmingham’s (UK) Experience

Sundus Yahya, Qamar Ghafoor, Robert Stevenson, Steven Watkins, Beshar Allos

Metabolic positron emission tomography parameters predict failure patterns in early non-small-cell lung cancer treated with stereotactic body radiation therapy: a single institution experience

Jeongshim Lee, Minkyung Lee, Woong Sub Koom, Hun Jung Kim, Woo Chul Kim

Japanese Journal of Clinical Oncology.2018; 48(10): 920. CrossRef